Shenzhen Leqing Medical Instrument Co., Ltd.

Shenzhen Leqing Medical Instrument Co., Ltd. specializes in physical therapy devices, specifically transcutaneous neuromuscular electrical stimulation (TENS/NMES) systems. These devices deliver targeted electrical impulses to muscles or nerves, primarily used for pain relief, muscle rehabilitation, and physical therapy. The company’s focus is on electronic stimulators designed for controlled therapeutic applications.

The company is based in the United States, which means its devices must comply with US regulatory standards. Since its products are classified as Class II devices, they undergo stricter scrutiny than Class I but not as rigorous as Class III. The US-based operations also align with registries like the FDA’s 510(k) and UDI systems, ensuring traceability and compliance tracking for these medical devices.

The company’s devices are listed in the FDA’s 510(k) and Unique Device Identifier (UDI) registries. The 510(k) process ensures that Class II devices meet safety and effectiveness requirements by demonstrating substantial equivalence to a legally marketed predicate device. The UDI system provides a standardized way to identify devices throughout their lifecycle, improving tracking, traceability, and regulatory compliance for electronic stimulators.

The company’s electronic stimulators fall under Class II classification, which means they pose moderate risk and require special controls beyond general controls to ensure safety and effectiveness. This classification requires manufacturers to follow specific regulatory pathways, such as the FDA’s 510(k) process, to demonstrate compliance with performance standards and labeling requirements before market introduction.